CYCLO THERAPEUTICS INC (CYTH) Stock Balance Sheet
NASDAQ:CYTH • US23254X2018
0.7206 USD
+0.01 (+1.39%)
At close: Mar 25, 2025
0.7199 USD
0 (-0.1%)
After Hours: 3/25/2025, 8:00:01 PM
| MRQ (2024-9-30) | 2023 (2023-12-31) | 2022 (2022-12-31) | 2021 (2021-12-31) | 2020 (2020-12-31) | ||||
|---|---|---|---|---|---|---|---|---|
| ASSETS | ||||||||
| Current Assets | ||||||||
| Cash Equivalents | 928.00K | 9.25M | 1.54M | 16.61M | 12.85M | |||
| Receivables | 187.70K | 122.40K | 50.00K | 540.00K | 110.00K | |||
| Inventories | 236.10K | 254.40K | 250.00K | 230.00K | 240.00K | |||
| Other Current Assets | 1.90M | 2.69M | 2.31M | 2.06M | 850.00K | |||
| Total Current Assets | 3.26M | 12.32M | 4.16M | 19.44M | 14.05M | |||
| Non-Current Assets | ||||||||
| PPE Net | 46.60K | 929.30K | 60.00K | 80.00K | 90.00K | |||
| Other Non-Current Assets | 1.95M | N/A | N/A | N/A | N/A | |||
| Total Non-Current Assets | 2.00M | 929.20K | 60.00K | 80.00K | 140.00K | |||
| TOTAL ASSETS | 5.25M | 13.25M | 4.22M | 19.52M | 14.19M | |||
| LIABILITIES | ||||||||
| Current Liabilities | ||||||||
| Short Term Debt | 12.18M | 0.00 | 0.00 | 0.00 | 0.00 | |||
| Current Portion Of LT Debt. | N/A | N/A | 0.00 | 130.00K | 110.00K | |||
| Accrued Expenses | 751.90K | 2.69M | 0.00 | 20.00K | 20.00K | |||
| Accounts Payable | 5.79M | 5.77M | 3.48M | 3.68M | 3.54M | |||
| Total Current Liabilities | 18.72M | 8.47M | 3.48M | 3.83M | 3.67M | |||
| Non-Current Liabilities | ||||||||
| Long Term Debt | 0.00 | 0.00 | 0.00 | 20.00K | 40.00K | |||
| Other Non-Current Liabilities | 7.10K | 22.50K | N/A | 0.00 | 20.00K | |||
| Total Non-Current Liabilities | 7.10K | 22.40K | 0.00 | 20.00K | 70.00K | |||
| TOTAL LIABILITIES | 18.73M | 8.49M | 3.48M | 3.85M | 3.74M | |||
| SHAREHOLDERS' EQUITY | ||||||||
| Retained Earnings | -103.01M | -83.86M | -63.80M | -48.35M | -34.06M | |||
| Additional Paid In Capital | 89.54M | 88.61M | 64.53M | 64.02M | 44.51M | |||
| Common Shares | 2.90K | 2.90K | 0.00 | 0.00 | 0.00 | |||
| Other Shareholders' Equity | N/A | N/A | N/A | N/A | N/A | |||
| Shares Outstanding | 28.77M | 28.56M | 8.48M | 8.40M | 4.77M | |||
| Tangible Book Value per Share | -0.47 | 0.17 | 0.09 | 1.87 | 2.19 | |||
| Total Shareholders' Equity | -13.47M | 4.76M | 730.00K | 15.67M | 10.45M | |||
| TOTAL LIABILITIES AND EQUITY | 5.25M | 13.25M | 4.22M | 19.52M | 14.19M | |||
| Statistics | ||||||||
| Debt/Equity | N/A | N/A | N/A | 0.00 | 0.00 | |||
| Current Ratio | 0.17 | 1.45 | 1.20 | 5.08 | 3.83 | |||
| Return On Assets (ROA) | -472.02% | -151.40% | -366.11% | -73.21% | -63.00% | |||
| Return On Equity (ROE) | N/A | -421.64% | -2116.44% | -91.19% | -85.55% | |||
All data in USD , ROIC based on taxRate of 0.21